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Alison Smith,t Ashby Taylor,§ and Blase A. Carabello*
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Abstract
Children with ventricular septal defect (VSD) often demon-
strate failure to thrive (Ff1'). Such patients usually have re-
duced systemic cardiac output which has been postulated as a
cause for their growth retardation. This study was conducted to
ascertain the mechanism of the reduced cardiac output in chil-
dren with VSD and FT1'1 and also in a porcine model of VSD.
Forward stroke volume was reduced in VSD-F'IT children,
31±8 ml/m2, compared to normal children, 49±15 ml/m2 (P
< 0.05), but was not reduced in children with VSD and normal
growth and development (41±16 ml/m2). Forward stroke vol-
ume was also reduced in swine with VSD compared to controls.
Contractility assessed by mean velocity of circumferential
shortening (Vd) corrected for afterload was similar in normals
and VSD-FT'I children. Contractile performance was also sim-
ilar in normal and VSD swine. Afterload assessed as systolic
stress was similar in FIT-VSD children and normal subjects.
Preload assessed as end-diastolic stress was increased in the
VSD-FI' group. End-diastolic volume was not larger in the
VSD-FTI' group. We conclude that the reduced stroke volume
seen in VSD-FT'I children and VSD-swine was not due to
reduced contractility, increased afterload or reduced preload.
The reduced stroke volume may have been due to failure of
end-diastolic volume to increase adequately.
Introduction
Children with ventricular septal defect (VSD)' often demon-
strate failure to thrive (FfT) (1-3). While several mechanisms
have been proposed to explain this phenomenon (4-10), the
observation that patients with the largest intracardiac shunts
demonstrate the most growth retardation suggests a cardiac
cause (8-9). Successful correction of the shunt leads to im-
proved growth and development further supporting a cardiac
etiology of FTT (11-15). One proposed mechanism is that
Address reprint requests to Dr. Carabello, Division of Cardiology,
Medical University of South Carolina, 171 Ashley Avenue, Charles-
ton, SC 29425.
Receivedfor publication 29 July 1987 and in revisedform 14 March
1988.
1. Abbreviations used in this paper: Emax, peak elastance; FTT, failure
to thrive; NGD, normal growth and development; SV,, ventricular
strike volume; VCf, velocity of circumferential fiber shortening; VSD,
ventricular septal defect.
reduced systemic cardiac output produces decreased tissue
perfusion which results in slowed growth and development (6,
8). Reduced cardiac output could be caused by impaired con-
tractile function, increased afterload, reduced preload or an
inadequate compensatory increase in left ventricular end-dia-
stolic volume. The current study was performed to investigate
which ofthese mechanisms reduced systemic cardiac output in
children with VSD and FTT. To do this, we compared cardiac
mechanics and contractile function at cardiac catheterization
in children with VSD and FTT to children with VSD and
normal growth and development (NGD), and to normal sub-
jects.
Because obvious ethical constraints limit investigation in
potentially unstable children with congenital heart disease, we
also studied a newly discovered naturally occurring porcine
model of VSD in which systemic stroke volume was reduced.
Study in an animal model permitted the use ofload manipula-
tion and beta blockade allowing a more precise evaluation of




Study design and patient selection. Hemodynamic and cardiac me-
chanics data were obtained at cardiac catheterization in 12 children
with ventricular septal defect who demonstrated failure to thrive
(group VSD-FTT), in 9 children with VSD who demonstrated normal
growth and development (group VSD-NGD), and in 11 normal chil-
dren (group NL). A child was considered to have FTT if his weight was
. the third percentile for children of that age and sex (>-2 standard
deviations from the mean) (16). Normal growth and development was
defined as achievement of2 the sixteenth percentile for children ofthe
same sex and age (<-1 standard deviation from the mean). Normal
subjects underwent cardiac catheterization before electrophysiologic
testing for cardiac arrhythmias. Children in whom catheterization
demonstrated no anatomic or physiologic cardiac abnormalities other
than arrhythmias, who were not taking cardiac medications and who
were in normal sinus rhythm at the time of study were selected to be
normal subjects. These subjects all exhibited normal growth and devel-
opment. The age and weight ofthe subjects studied is shown in Table I.
Analysis of the patients' records demonstrated that when VSD-NGD
patients were of a similar age (1.65±0.8 yr) to the VSD-F-TT children,
the VSD-NGD patients still demonstrated NGD, average weight per-
centile 40±15.
Catheterization reports for procedures performed from 1 January
1984 to I January 1987 were screened to identify patients with isolated
ventricular septal defects and to identify normal subjects. 49 subjects
with isolated VSD and 22 normal subjects were identified. Patients
were then included for study if they met the following criteria: (a) The
ratio of pulmonary to systemic blood flow for the patients with VSD
was at least 1.75 to 1. (b) Adequate ventriculograms were available for
analysis. An adequate ventriculogram was one in which diastolic, sys-
tolic, and wall thickness silhouettes were clearly discernable and in
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Table I. Age and Weight ofPatients
Controls VSD-NGD VSD-FTT
Weight (kg) 22±12 17±7 8±4*t
Weight percentile 53±27 41±17 <3*§
Age (yr) 6.3±3.5 4.5±3.1 1.9±1.5*
* P < 0.01 vs. controls; t P < 0.05 vs. VSD-NGD; § P < 0.01 vs.
VSD-NGD.
Absence of sign indicates no significant difference.
which two consecutive sinus beats were available for analysis. (c) Prop-
erly damped and calibrated pressure tracings were available for review.
21 subjects with isolated VSD (12 with FTT and 9 with NGD) and 11
normal subjects met these criteria and were chosen for study.
Catheterization procedure. Children were premedicated with 2
mg/kg meperidine and 1 mg/kg promethazine. Pressures were re-
corded using properly damped, fluid-filled catheters. Hemoglobin ox-
ygen saturation was determined by reflectance oximetry in the aorta,
left ventricle, pulmonary artery, right ventricle, right atrium, and
venae cavae. The ratio of pulmonary to systemic blood flow was cal-
culated as: QP/QS = LV sat - RA sat/LV sat - PA sat, where LV sat
= % oxygen saturation in the left ventricle, PA sat = oxygen saturation
in the pulmonary artery, and RA sat = oxygen saturation in the right
atrium.
Ventriculography was performed at 60 frames/s in the 30° degree
right anterior oblique position. Pressure measurements were taken just
before ventriculography. Premature and post-premature beats were
excluded from analysis.
Measurements and calculations. Total angiographic left ventricular
stroke volume was calculated as end-diastolic volume minus end-sys-
tolic volume where volume was derived by the area-length method
(17). Volumes were indexed by dividing by body surface area. Forward
systemic angiographic stroke volume was calculated as total left ven-
tricular stroke volume divided by the shunt ratio. Angiographic sys-
temic cardiac output = angiographic systemic stroke volume X heart
rate.
Wall thickness was measured at end diastole along the mid-portion
of the anterior left ventricular wall. The systolic increase in wall thick-
ness was then calculated using the assumption that left ventricular
mass remains constant throughout the cardiac cycle (18). Circumfer-
ential wall stress was calculated frame by frame using Mirsky's (19)
formula. Frame by frame analysis allowed us to measure end-systolic
stress, peak systolic stress, and mean systolic stress. Mean-systolic
stress was calculated by summing the individual systolic frame stresses
and dividing by the total number of frames.
Left ventricular mass, expressed in grams, was calculated after the
method of Rackley et al. (20).
Left ventricular contractile function was assessed using the after-
load-corrected mean velocity of circumferential fiber shortening
method (Vd-stress) (21-24). This method corrects a preload indepen-
dent ejection phase index (mean VCf) (25) for afterload (wall stress)
yielding a relationship which is independent of preload and corrected
for afterload, thus reflecting contractile state. Vcf and mean stress were
plotted for the 11 normal subjects. We used mean systolic stress since
mean Vd2 is measured over all of systole. Patients with VSD were then
plotted against the 95% prediction band for the normal data. Vcf was
calculated as: EDD - ESD/EDD X ET, where EDD = end diastolic left
ventricular minor axis, ESD = end-systolic minor axis, and ET
= ejection time, calculated as the total number offrames during which
shortening occurred X 0.0 166 s/frame. This method was used since in
VSD patients ejection could have occurred before the upstroke of the
aortic pressure tracing and following the dicrotic notch, the usual
markers for measuring ejection time.
Patient followup. Patient followup was obtained by review of the
patients' hospital charts at the time of their followup clinic visits after
cardiac surgery. This followup data was used to ascertain symptomatic
status and growth and development following the correction of
the VSD.
Animal studies
Anesthesia. 13 fasted Yucatan micro swine (Charles River Breeding
Laboratories, Wilmington, MA) of both sexes, 5 with normal cardiac
anatomy, and 8 with a congenital high membranous VSD, were inves-
tigated by cardiac catheterization. On the day of study, the animals
were placed in a sling, and initially sedated with isoflurane 2% deliv-
ered with 100% 02- When adequate relaxation had been achieved, the
swine were intubated but continued to breathe without assistance.
They were attached to a Jackson-Reese non-rebreathing ventilation
circuit through which they received isoflurane 2 to 2.75% and ambient
air, without supplemental oxygen. While breathing this mixture, arte-
rial oxygen saturation remained > 90%. Of the inhalational fluorocar-
bons, isoflurane has the least impact upon inotropic function (26-29).
However as isoflurane has been shown to reduce contractility (30), care
was taken to utilize the minimum dose necessary to maintain surgical
anesthesia and to administer the drug within a narrow dose range.
There was no difference in the concentration of isoflurane used in the
two groups of swine.
Catheterization. Right and left heart catheterizations were per-
formed under sterile conditions from either the percutaneous ap-
proach or by direct exposure of the cervical or femoral vessels. A
balloon-tipped flow directed Swan-Ganz catheter was used for right
heart catheterization. Left heart catheterization was performed using a
5-F Bermann catheter, which permitted both pressure and oxygen
saturation determinations, and with which left ventriculography was
performed. A 6-F micromanometry catheter (Millar Instruments,
Houston, TX) was introduced into the ascending aorta in order to
measure central aortic pressure simultaneously with ventriculography.
Load manipulation was accomplished by inflation and deflation of
either a 15- or 18-mm valvuloplasty balloon that had been positioned
from the superior into the inferior vena cava. All pressure, oximetry
and cardiac output data were obtained prior to ventriculography.
Shunt and cardiac output determinations. Oxygen saturation was
determined in duplicate from the pulmonary artery, right ventricle,
right atrium, vena cavae, and left ventricle using an OSM2 Hemoxi-
meter (Radiometer A/S, Copenhagen, Denmark). These data were
utilized to calculate the shunt ratio (QP/QS) as reported under human
studies. Blood hemoglobin (Hb, g/dl) concentration was measured
using the OSM2 Hemoximeter. The systemic cardiac output was cal-
culated from the Fick method as: Cardiac output (liters/minute)
= VO2J(A - V 02 A), where V02 = oxygen consumption per minute
determined using a Tissot respirometer (ml 02/min); A - VO2A = the
difference between the oxygen content of arterial and venous blood
was determined as:
A - V 2A (ml 02/liter)
= Hb (g/liter) - (LV - RA) - (1.36 ml 02/g Hb),
where Hb = hemoglobin concentration, and (LV - RA) = oxygen
saturation of the left ventricle - oxygen saturation in right atrium.
Pulmonary blood flow was calculated as the product of systemic car-
diac output and the shunt ratio.
Ventriculography and volume determinations. Left ventriculogra-
phy was performed in the right anterior oblique (30°) position using 35
mm film at a rate of 60 frames per second. Left ventricular volume,
thickness and mass were calculated as described under human studies.
Cardiac output and stroke volume were determined by both the Fick
and angiographic methods. Angiographic left ventricular stroke vol-
ume (SVA) was determined as: SVA (ml) = End-diastolic volume (ml)
- end-systolic volume (ml). Fick total left ventricular stroke volume
(SVt) was determined as: SVt (ml) = (systemic blood flow + shunt
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blood flow)/heart rate. Fig. 1 demonstrates a close correlation between
values obtained using the two techniques.
30 min following the baseline ventriculogram, beta adrenergic
blockade was achieved and angiography was repeated during which
load was manipulated for assessment of contractile function.
Assessment of contractile function. Contractile function was as-
sessed by several methods. We calculated peak elastance (Emax),
which has been shown to be relatively independent ofpreload, account
for afterload and to reflect inotropic state (31-34). Because Emax can
be affected by cardiac size independent of inotropic state (35, 36), we
also evaluated contractility using Emax corrected for end-diastolic
volume. Contractile function was also analyzed using the afterload-
corrected velocity of circumferential fiber shortening (Vdrstress rela-
tionship) (21-24). This relationship has an advantage of being dimen-
sionless and therefore is independent of cardiac size.
The Emax and stress-corrected V(f relationships were obtained for
each animal by load manipulation during a single ventricular contrast
(Renographin 76) injection. Arterial pressure was reduced for - 10 s
by inflation of the vena caval balloon. The nadir of peak-systolic pres-
sure was maintained above 60 mmHg to assure adequate coronary
perfusion (37). Simultaneous left ventricular injection and aortic ma-
nometry were carried out during subsequent balloon deflation. Bal-
loon deflation produced a beat to beat increase in systemic pressure,
yielding beat to beat load alteration. Four to six beats were analyzed
per deflation. Contractile function was determined after propranolol (1
mg/kg i.v.) administration in all of the experimental animals and be-
fore and after propranolol administration in a subgroup of six. This
subgroup study was performed to test the ability of our methods to
detect a change in contractile function when a known negative inotro-
pic agent was administered. Successful beta blockade was confirmed by
the absence ofan increase in heart rate during isoproterenol (1.0 ;ig/kg
per min) administration, performed after all contractile studies had
been completed.
Emax was determined as the slope of the pressure-volume rela-
tionship derived from all of the analyzed beats during load manipula-
tion. A high correlation coefficient (r 2 0.95) was obtained for each
animal (example, Fig. 2). Emax was corrected for end-diastolic volume
(Emax) by multiplying Ema,, by end-diastolic volume.
The Vf-stress relationship was determined frame by frame as de-
scribed under human studies. However, unlike in our patients where
only one Vcf-stress point was available per subject, in swine a VCf-stress
point was produced for each differently loaded cardiac cycle. An expo-
nential regression ofmean stress vs. the velocity offiber shortening was
determined using data from all analyzed beats (21, 22) (example, Fig.
3). Values for VCf at the common mean stress levels of 50 and 100
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Figure 1. Angiographic versus Fick stroke volume. Angiographically
determined stroke volume in swine is plotted against stroke volume
determined by the Fick method. A close correlation is demonstrated.
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s Baseline y = 3.2x-17.7 r=0.99
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Figure 2. Emax determination. Maximum elastance (Emax) was cal-
culated in the Yucatan swine as the slope ofthe end-systolic pres-
sure-end-systolic volume relationship. Four to six beats were utilized
in each analysis, and the coefficient of correlation was 2 0.95 in all
cases. Emax declined after propranolol administration.
Statistics. Statistical comparison ofthe three groups ofchildren was
performed by a one-way analysis of variance followed by a Tukey test
for pairwise comparison. The exponential Vcf-stress relationship and
95% prediction band were obtained from the individual data ofcontrol
children using standard statistical formulae (38). Comparison of the
control swine with the VSD swine was made using a two-tailed t test for
independent groups. A paired t test was used to compare swine evalu-
ated before and after propranolol administration. Linear regression by
the least squares method was used to develop the Emax relationship
and for comparing angiographic and Fick stroke volume. Comparisons
were considered statistically significant at the P = 0.05 level. All data
are presented as the mean± I standard deviation.
Results
Human studies
Hemodynamic and cineangiographic data. Cardiac catheter-
ization data are presented in Table II. The heart rate was simi-
lar among the three groups. Angiographically determined car-
diac index and forward stroke volume index (Fig. 4) were re-




Figure 3. Vrdstress determination. Exponential regression of the
mean velocity of circumferential fiber shortening (VVcf)-mean sys-
tolic stress data in the baseline state (closed boxes) is presented for a
Yucatan swine with a ventricular septal defect. Contractility was as-
sessed by calculating Vcf at the common end-systolic stress of 50 and
100 kdyn/cm2.
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Table II. Patient Hemodynamic and Cineangiographic Data
Controls VSD-NGD VSD-FTT
HR (bpm) 103±20 98±13 115±13
CI (i/minIm2) 5.0±1. 4 3.9±1.4 3.4±0.9*
FSVI (ml/M2) 49±15 41±16 31±8*
TSVI (ml/m) 49±15 85±23$ 86±20t
QP/QS 2.3±0.8 2.8±0.6
EDVI (mi/M2) 75±21 137±34* 143±48t
ESVI (m/rM2) 25±9 48±27* 59±28*
LVMI (g/m2) 73±18 109±27* 112±22*
RVEDP (mmHg) 7±3 9±2 9±2
RVSP (mmHg) 23±7 33±12 65±19*§
LVEDP (mmHg) 8±3 12±3t 12±2t
LVSP (mmHg) 107±13 95±10 98±15
PAP (mmHg) 15±5 22±8 46±13$§
PVRI (dyn/s/cmn5/m21 118±70 287±204 754±315$§
SVRI (dyn/s/cm-5/m2) 1,386±626 1,519±428 1,634±576
EDS (kdyn/cm2) 29±8 45±15* 47±12t
ESS (kdyn/cM2) 127±30 136±45 143±60
PSS (kdyn/cM2) 303±66 295±62 305±74
MSS (kdyn/cm2) 213±41 222±45 221±66
EF 0.66±0.07 0.65±0.08 0.62±0.09
VCf(c/s) 1.18±0.19 1.17±0.25 1.13±0.18
HR, heart rate; CI, systemic cardiac index; FSVI, forward stroke vol-
ume index; QP/QS, ratio of pulmonary to systemic blood flow;
EDVI, end-diastolic volume index; ESVI, end-systolic volume index;
EF, ejection fraction; ESS, end-systolic stress; EDS, end-diastolic
stress; LVMI, left ventricular muscle mass index; PAP, mean pulmo-
nary artery pressure; TSVI, total stroke volume index; RVEDP, right
ventricular end-diastolic pressure; RVSP, right ventricular peak sys-
tolic pressure; LVEDP, left ventricular end-diastolic pressure; LVSP,
left ventricular peak systolic pressure; PVRI, pulmonary vascular re-
sistance index; SVRI, systemic vascular resistance index; PSS, peak
systolic stress; MSS, mean-systolic stress; * P < 0.05 vs. controls; * P
< 0.01 vs. controls; § P < 0.01 vs. VSD-NGD. Absence of a sign in-
dicates no statistically significant difference was present.
duced in group VSD-FNT (31±8 ml/m2) compared to normal
(NL) subjects (49±15 mi/M2, P < 0.05), while forward stroke
volume in VSD-NGD 41±16 mi/M2 was similar to group NL.
The shunt ratio was somewhat larger in the VSD-FlTT group
but this difference did not reach statistical significance. The
end-diastolic volume index was significantly increased in
VSD-NGD (137±34 mi/M2) and in VSD-FTT (143±48
ml/m2) compared to NL (75±21 mi/M2, P < 0.01). End-sys-
tolic volume was increased in both groups with VSD com-










even after indexing for
body surface area was
reduced in children
with VSD and ITT,
compared to those with
VSD and NGD and
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Figure 5. VK-stress in children. The Vcf mean-systolic stress (MSS) re-
lationship is presented for normal subjects (closed boxes), children
with VSD and NGD (VSD-NGD, open boxes) and children with
VSD and failure to thrive (VSD-FlT, stars). The exponential regres-
sion function derived from the individual control data is indicated
with its 95% prediction band. There was nearly complete overlap of
the data, and all but one patient from all three groups fell within the
95% prediction band. This finding suggests that contractile function
is normal in these patients with VSD.
stress, peak-systolic stress and mean-systolic stress were similar
among the three groups. End diastolic stress was elevated in
VSD-FTT (47±19 kdyn/cm2) and VSD-NGD (45±15 kdyn/
cm2) compared to NL (29±8 kdyn/cm2, P < 0.01). The left
ventricular muscle mass index was increased in both VSD
groups compared to NL (P < 0.01). The pulmonary artery
pressure was increased in VSD-FTT compared to the other
groups (P < 0.01).
The mean velocity of circumferential fiber shortening,
end-systolic stress relationship is presented in Fig. 5. Individ-
ual data from each of the patients and the exponential regres-
sion relationship derived from the normal subjects are shown.
There is nearly complete overlap of patient data from each
group, and all VSD patients fell within the 95% prediction
band for normal subjects except for one patient who fell out-
side up and to the left suggesting that contractile function was
increased.
Postoperative clinical data. Followup data from ambula-
tory clinic records were available for all but two children (one
from each VSD group) and are presented in Table III. All
children with FTT underwent operation, one of whom died
Table III. Postoperative Clinical Data
VSD-NGD VSD-FT-
Age at followup (yr) 5.9±3.5 3.3±2.1
Followup after operation (mo) 15±8 12±9
Postop weight gain (kg) 4.9±2.4 4.4±1.9
Postop weight increase compared to
predicted (%) 121± 32 158±62
Postop weight percentile 60±20 20±20$
(45±20) (<3)
* P < 0.001 VSD-NGD vs. VSD-FTT; * P < 0.01 vs. preoperative
VSD-FTT. Preoperative weight percentiles are indicated in parenthe-
ses.







during surgery. 7 of 9 NGD patients had repair of the VSD. A
minimal residual postoperative defect remained in 3 of 11
FTT patients and in 2 of the 7 NGD children who underwent
operation (NS). Postoperative followup was similar for pa-
tients in both groups. Absolute postoperative weight gain and
weight gain as a proportion of that predicted for the patient's
age, were similar in the two groups. Postoperatively, the mean
weight ofgroup VSD-NGD continued to exceed that for group
VSD-FlTT (P < 0.05). However, the postoperative weight per-
centile increased significantly in group VSD-FTT following
surgical repair, but did not in group VSD-NGD. In addition, 9
of the 11 children preoperatively classified as failure to thrive
were classified as having normal growth and development at
the time of clinical followup.
Yucatan swine data. The data obtained at cardiac catheter-
ization of the Yucatan micro swine are presented in Table IV.
VSD swine were older than their controls (P < 0.05), but the
two groups did not differ in their body weight. Thus, it took the
VSD swine longer to achieve the same weight as controls.
Table IV. Yucatan Swine Data
Controls VSD
QP/QS 2.3:1±1.1
Age (wk) 21±1 27±4*
Wt (kg) 21±2 25±7
HR (bpm) 116±13 122±21
LVMI (g/kg) 2.4±0.4 2.9±0.8
EDVI (ml/kg) 1.9±0.5 2.2±0.8
ESVI (ml/kg) 0.8±0.3 0.9±0.4
EF 0.58±0.08 0.57±0.08
IP (mmHg) 81±8 73±11
PAP (mmHg) 21±10 20±6
PCW (mmHg) 4±4 9±5
V02 (ml/m/kg) 2.6±0.3 2.8±0.2
FSVI (ml/kg) 1.1±0.26 0.65±0.11t
CI (liters/min/kg) 0.12±0.03 0.08±0.01*
SVRI (dyn s/cm5.kg) 152±71 127±67
PVRI (dyn * s/cm5 *kg) 37±17 11±5§
EDS (dyn/cm2) 9±5 22±11*




V'100 (circ/s) 0.68±0.14 0.70±0.13
QP/QS, ratio of pulmonary to systemic blood flow; Wt, body weight;
HR, heart rate; LVMI, left ventricular muscle mass index; EDVI,
end-diastolic volume index; ESVI, end-systolic volume index; EF,
ejection fraction; IP, incisural pressure; PAP, mean pulmonary artery
pressure; PCW, pulmonary capillary wedge pressure; V02, oxygen
consumption; FSVI, forward stroke volume index; CI, systemic car-
diac index; SVRI, systemic vascular resistance index; PVRI, pulmo-
nary vascular resistance index; EDS, end-diastolic stress; ESS, end-
systolic stress; Emax, maximum systolic elastance; Emax', Emax
corrected for end-diastolic volume; Vcf50, Vcfloo, mean velocity of cir-
cumferential fiber shortening at a common end-systolic stress of 50
and 100 kdyn/cm2.
* P < 0.05 vs. controls; * P < 0.001 vs. controls; § P < 0.01 vs. con-
trols. Absence of a sign indicates no statistically significant difference
was present.
Heart rate, left ventricular muscle mass index, end-systolic
volume index and ejection fraction were also similar in the two
groups. Incisural pressure, mean pulmonary artery pressure
and pulmonary capillary wedge pressure and A-VO2 difference
were also similar in the two groups. VSD animals had a signifi-
cantly reduced forward stroke volume index (0.65±0.11 vs.
1.1±0.26 ml/kg, P < 0.001) and systemic cardiac index
(0.08±0.01 vs. 0.12±0.03 1/kg, P < 0.001). While systemic
vascular resistance index was similar, pulmonary vascular re-
sistance index was significantly reduced (P < 0.01) in swine
with VSD. End-diastolic stress was elevated in the group with
VSD (22±11 vs. 9±5 kdyn/cm2, P < 0.05) but end-diastolic
volume index was similar in the two groups- 1.9±0.5 cm3/kg
normal, vs. 2.2±0.8 cm3/kg VSD. End-systolic stress was simi-
lar in the two groups.
Indices of contractile function demonstrated no difference
between the VSD swine and controls. Emax (1.5±0.8, VSD vs.
2.2±0.7, Controls) and Emaxc (68±30, VSD vs. 84±27, con-
trols) were similar, as were Vcf at the common mean-systolic
stress levels of 50 (0.99±0.15 circ/s, VSD vs. 1.04±0.14 circ/s,
controls) and 100 (0.70±0.13 circ/s, VSD vs. 0.68±0.14 circ/s,
controls) kydn/cm2 (Fig. 6).
Contractile function data in the subgroup of six animals
studied before and after administration ofpropranolol demon-
strated a reduction in Emax, Vcf50 and Vcfloo after institution of
beta blockade: Emax decreased from 2.8±0.4 to 2.1±0.5 (P
< 0.01), Vcfs0 fell from 0.95±0.12 to 0.75±0.09 (P < 0.05) and
VCfloo fell from 0.72±0.15 to 0.54±0.09 (P < 0.001).
Discussion
Our study confirmed that VSD complicated by FTT is asso-
ciated with decreased systemic cardiac output and forward
stroke volume. Although previous investigators have suggested
that FVT in VSD is due to decreased caloric intake (7), in-
creased metabolic rate (10), or decreased absorption (4), Miller
et al. (8) found decreasing systemic blood flow with increasing
shunt ratio and suggested a cardiac cause in patients with VSD
and FVT. They also described an inverse relationship between
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Figure 6. V,,-stress in swine. The mean velocity of circumferential
fiber shortening (VCf) at the common mean-systolic stress levels of 50
(SS 50) and 100 (SS 100) kdyn/cm2 following beta blockade are
shown for Yucatan micro swine with congenital ventricular septal
defects (striped histogram) and for controls (black histograms). Ve-
locity of shortening was similar at both levels of stress, suggesting
similar contractility in the two groups.
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found that growth was inversely related to the shunt ratio in
VSD. Further support for a direct cardiac cause of FITT in
VSD is given by studies which show a return to normal growth
and development after the cardiac defect is repaired (1 1-15).
Our study was designed to determine the mechanism of
reduced forward cardiac output in VSD-FlTT. At a given heart
rate, systemic cardiac output is determined by forward stroke
volume. Forward stroke volume in VSD is a function of shunt
size, myocardial contractility, afterload, preload, and ventricu-
lar volume. We examined each of these hemodynamic factors
to assess their contribution to the diminished forward flow
observed.
Contractile function. An important finding in our study
was that contractile function was normal in subjects with VSD
and FT'T. Myocardial contractile function was assessed using
ejection fraction, uncorrected mean velocity of circumferen-
tial fiber shortening (V'd) and the stress-velocity relationship.
Ejection fraction was similar in the three groups of children.
Ejection fraction is however both preload and afterload de-
pendent (39). The uncorrected VCf, a preload independent
index of contractility (25) was also similar in the three groups
but this index varies inversely with afterload (23). Correction
of VIf for afterload (systolic stress) yields a relatively load inde-
pendent measure of contractile function (23). Stress-corrected
Vcf (Fig. 5) was similar in the controls and in children with
VSD. These data suggest that contractile function was normal
in our children with VSD with or without FTT and was not the
cause of the reduced stroke volume found in VSD-FTT group.
Relationship to other studies ofcontractilefunction. Others
have suggested that contractile function is reduced postopera-
tively in patients with VSD. One year after operation, Maron
et al. (40) found a reduced cardiac output during exercise in
postoperative VSD patients compared to nonoperated con-
trols. A reduced inotropic reserve was suggested as the cause.
Jarmakani et al. (41) studied postoperative VSD patients and
compared their results to those of a non-operated normal
group. Resting ejection fraction and Vmax were decreased in
the VSD group. However the catheterization of the VSD pa-
tients in this study was performed under halothane anesthesia,
a known negative inotrope. Jablonsky et al. (42) found that
postoperative VSD patients demonstrated a decreased resting
ejection fraction and a blunted increase of ejection fraction
during exercise compared to their controls. In all of the above
studies however, the controls were a nonoperated group and
thus it is not clear whether the observed abnormalities in car-
diac performance were due to the VSD or surgery. In contrast
our study is in agreement with several recent studies (43-45)
which found normal ventricular function in VSD patients
compared to controls. It is likely that the unavailability of
intraoperative myocardial preservation techniques affected the
results of the earlier investigations.
To help resolve the above conflicting reports and because
adrehergic support could have concealed an inotropic deficit
in our patients, we further studied contractile function in an
experimental animal model ofcongenital VSD in which stroke
volume was also diminished and in which load manipulation
and beta blockade could be ethically performed. Load manip-
ulation allowed us to generate the peak elastance (Emax), vol-
ume-corrected peak elastance (EmaxJ) and stress-corrected Vd
relationships, which have been used in previous studies to as-
sess contractile function (21-24, 31-36). Evaluation of con-
tractile function was performed during one ventricular con-
trast injection avoiding the use of pharmacologic agents to
manipulate load which might by themselves have affected
contractile function. The adequacy of beta blockade was con-
firmed by the absence of a chronotropic response to adminis-
tration in pharmacologic doses of the beta agonist isoproter-
enol. The results in swine, like those in children indicate no
reduction in contractile function as the cause of the reduced
stroke volume which we observed.
To assess the sensitivity of our contractile indices to
changes in function, we compared Emax, V,-50 and V,,noo be-
fore and after propranolol administration. Emax, and velocity
of circumferential shortening at both levels of mean-systolic
stress, declined after propranolol administration. Thus, our
methods correctly demonstrated the reduction in contractile
function produced by a known negative inotropic drug. There-
fore the absence of a difference between VSD and controls was
probably not due to an inability to discern changes in function
had any been present.
Afterload. Afterload, assessed as the end-systolic stress,
peak-systolic stress or mean systolic stress was similar in the
three groups of children and in both groups of swine. In addi-
tion, calculated systemic vascular resistance in swine was simi-
lar in the control and VSD groups. Thus the reduced systemic
cardiac output was not likely due to increased afterload.
Preload. Preload was evaluated as end-diastolic pressure
and end-diastolic stress. Both were increased in both groups of
VSD children compared to normals. At the myocardial level,
preload is the extent of stretch of individual sarcomeres. We
were not able to evaluate sarcomere length in our group of
patients or cohort of swine. However, that end-diastolic stress
was increased in the group ofchildren with VSD and FTeT, and
in swine suggests that reduced preload was not responsible for
the diminished forward stroke volume found in these subjects.
End-diastolic volume and shunt size. When forward stroke
volume is reduced by an intracardiac shunt, systemic flow can
be augmented by ventricular enlargement. Both groups of
children with VSD exhibited such an increase in end-diastolic
volume. However, shunt size was somewhat larger (21%) in
VSD-FTT than VSD-NGD. Although this difference was not
statistically significant, it may have been "clinically" signifi-
cant. The 21% larger shunt size was coincident with the 25%
fall reduction in forward stroke volume, which was statistically
significant. In the absence of reduced contractile function, re-
duced preload or increased afterload, it is possible that it was
end-diastolic volume which, although increased, was not in-
creased enough to maintain normal forward stroke volume in
the face of possibly larger shunts in the children with FIT.
This argument is further strengthened by the finding that a
similar inadequate (and insignificant) increase in end-diastolic
volume occurred in swine.
The failure of the left ventricle to sufficiently enlarge in
children with F-T is an observation in clear contrast to other
chronic volume overload states. In the adult with compensated
chronic mitral regurgitation or aortic insufficiency, adequate
eccentric hypertrophy occurs to maintain forward stroke out-
put (46, 47). Grossman has hypothesized that increased end-
diastolic stress is the major stimulus to eccentric hypertrophy
and cavity dilatation. However in both VSD groups, end-dia-
stolic stress was increased. It is possible that some theoretic
limit to the extent of hypertrophy prevented further increases
in end-diastolic volume needed to compensate the somewhat
large shunts in the VSD-FTT children.
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Limitations. The validity of our results suggesting that for-
ward stroke volume is reduced and that end-diastolic volume
is not appropriately augmented in children with VSD and
FTT, rests upon our ability to accurately measure ventricular
volume by standard angiographic techniques. Although these
techniques have known limitations (48), the identical tech-
niques were applied to all three groups of children thus avoid-
ing introduction of a systematic error affecting one group. Our
angiographic measurements were validated in the swine model
where systemic cardiac output and stroke volume measured
independently by ventriculography and by the Fick method
were similar. The close relationship between cardiac output
and stroke volume derived from these two techniques, helps
confirm the validity of our measurements and our conclusions
that VSD-FTT is associated with reduced forward stroke vol-
ume. Our pressures were recorded just before, but not simulta-
neously with, angiography in our children. While this could
have introduced error, there was no evidence that the hemody-
namics changed in this short interval between recording and
injection. In the swine, pressure recording and angiography
were simultaneous.
We utilized isoflurane, a negative inotropic agent during
cardiac catheterization in our cohort of swine. Differential use
of the drug between controls and VSD animals could have
altered our conclusions regarding contractile function. How-
ever, isoflurane was used at the lowest concentration permit-
ting catheterization, and within a narrow dose range that did
not differ between swine with VSD and controls; both groups
of swine received a similar dose of anesthesia. Therefore, it is
unlikely that our use of anesthesia differentially altered con-
tractile function in controls versus the VSD group of swine.
Conclusion. In the presence of a congenital VSD, FTT is
commonly observed. In this study, FTT was associated with a
decreased systemic output and forward stroke volume. We
conclude that reduced stroke volume was not due to impaired
contractile function, excess afterload, or reduced preload. The
exact mechanism for the reduced stroke volume remains spec-
ulative, however, it probably occurred secondary to a failure of
end-diastolic volume to increase adequately despite the pres-
ence of an increased end-diastolic stress.
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